Price (GBX)
340.00 -%
Open / Last close
- / 340.00
High / Low
340.00 / 332.50
Bid / Offer
335.00 / 345.00
Special Condition: -
Trading Status: Market Close
As at 05.06.20 17:36:12 - All data delayed at least 15 minutes

Faron Pharmaceuticals Oy instruments

Select instrument to view
Equity (1)
Code Instrument name Price Change Type Documentation

Price information

What's this?
Open price
Previous close price / date
340.00 / 05 June 2020
52 week range
80.50 / 492.00
YTD return
1 year return

Instrument information

What's this?
Instrument market cap (£m)
Earnings per share
Dividend (yield)
- %
Issue date
17 November 2015
Market identifier code (MIC)
Country of share register
Market segment
Trading service
Date Time Price CurrencyVolume Trade ValueTrade type Trade flag MIC
05.06.20 16:25:44 336.50 GBX 327 1,100.36 Off-Book - AIMX
05.06.20 16:12:20 344.50 GBX 288 992.16 Off-Book - AIMX
05.06.20 15:59:14 336.50 GBX 625 2,103.13 Off-Book - AIMX
05.06.20 15:34:14 336.50 GBX 500 1,682.50 Off-Book - AIMX
05.06.20 14:55:05 336.50 GBX 400 1,346.00 Off-Book - AIMX

Equity Research

from Faron Pharmaceuticals Oy
SP Angel Healthcare Conditions

Novacyt S.A. (NCYT.L): Supply contract with UK Department of Health and Social Care | Omega Diagnostics (ODX.L): Group performs CE-marking of Mologic Ltd’s COVID-19 antibody test | RenalytixAI (RENX.L): Utah Commercial Laboratory Facility Achieves ISO 13485 Certification | Faron Pharmaceuticals Oy (FARN.L): Inclusion of Traumakine in the WHO SOLIDARITY trial

View report
Small Cap Feast

Caribbean Investment Holdings. Incorporated in Belize . CIHL primarily operates financial services businesses through its subsidiaries The Belize Bank Limited and Belize Bank International Limited, both located in Belize and international corporate services through Belize Corporate Services Limited. CIHL shares are also traded on the Bermuda Stock Exchange. Lord Ashcroft holds 75%. No capital raise. Due 28 April. £36m . 2019 net profit US$ 10.7m

View report
SP Angel Healthcare Conditions

Diurnal (DNL.L): Marketing Authorisation Application validation | Faron Pharmaceuticals (FARN.L): Inclusion of Traumakine in pneumonia trial

View report
Small Cap Feast

Calisen Group. Potential Intention to Float. Owner and manager of essential energy infrastructure assets . Consolidated FY Dec 18 revenue £162.1m and operating profit £25.4m. Raising up to £300m in primary plus partial vendor sale. The Global Sustainable Farmland Income Trust will invest in a diversified portfolio of operational farmland assets located in major agricultural markets including the United States, Europe, New Zealand, Australia and certain countries within Latin and South America. R

View report
SP Angel Healthcare Conditions

Faron (FARN.L): Data from Phase 1/2 MATINS trial – from yesterday | Arix Bioscience (ARIX.L): Antibiotic portfolio company narrowly misses endpoint in Phase 3 trial – from yesterday

View report
Issuer presentations live and on demand
Watch on Spark Live